scholarly journals Deep phylogenetic analysis of Orthocoronavirinae genomes traces the origin, evolution and transmission route of 2019 novel coronavirus

2020 ◽  
Author(s):  
Amresh Kumar Sharma ◽  
Anup Som

The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan city, China in December 2019 and thereafter its spillover across the world has created a global pandemic and public health crisis. Today, it appears as a threat to human civilization. Scientists and medical practitioners across the world are involved to trace out the origin and evolution of SARS-CoV-2 (also called 2019 novel coronavirus and referred as 2019-nCoV), its transmission route, cause of pathogenicity, and possible remedial action. In this work, we aim to find out the origin, evolutionary pattern that led to its pathogenicity and possible transmission pathway of 2019-nCoV. To achieve the aims we conducted a large-scale deep phylogenetic analysis on the 162 complete Orthocoronavirinae genomes consisting of four genera namely Alphacoronavirus, Betacoronavirus, Deltacoronavirus and Gammacoronavirus, their gene trees analysis and subsequently genome and gene recombination analyses. Our analyses revealed that i) bat, pangolin and anteater are the natural hosts of 2019-nCoV, ii) outbreak of 2019-nCoV took place via inter-intra species transmission mode, iii) host-specific adaptive mutation made 2019-nCoV more virulent, and iv) the presence of widespread recombination events led to the evolution of new 2019-nCoV strain and/or could be determinant of its pathogenicity.

Biology ◽  
2020 ◽  
Vol 10 (1) ◽  
pp. 10
Author(s):  
Antoine Danchin ◽  
Tuen Wai Ng ◽  
Gabriel Turinici

Background: Starting late 2019, a novel coronavirus spread from the capital of the Hubei province in China to the rest of the country, then to most of the world. To anticipate future trends in the development of the pandemic, we explore here, based on public records of infected persons, how variation in the virus tropism could end up in different patterns, warranting a specific strategy to handle the epidemic. Methods: We use a compartmental model to describe the evolution of an individual through several possible states: susceptible, infected, alternative infection, detected, and removed. We fit the parameters of the model to the existing data, taking into account significant quarantine changes where necessary. Results: The model indicates that Wuhan quarantine measures were effective, but that alternative virus forms and a second propagation route are compatible with available data. For the Hong Kong, Singapore, and Shenzhen regions, the secondary route does not seem to be active. Conclusions: Hypotheses of an alternative infection tropism (the gut tropism) and a secondary propagation route are discussed using a model fitted by the available data. Corresponding prevention measures that take into account both routes should be implemented to the benefit of epidemic control.


2021 ◽  
Vol 1 (2) ◽  
pp. 153-160
Author(s):  
Akram Belmehdi ◽  
Saliha Chbicheb

The pandemic of coronavirus disease (COVID-19) is considered as the biggest global health crisis for the world since the Spanish flu, also known as the 1918 flu pandemic. Driven by the SARS-CoV-2 novel coronavirus infection, the rapid spread of this disease and the related pneumonia COVID-19 are a challenge for healthcare systems in over the world, and it is a constantly evolving situation with new symptoms and prognostic factors. SARS-CoV-2 has lately been detected in infected patient’s oral cavity; the COVID-19 outbreak is an alert that all dental and other health professionals must be vigilant in defending against the infectious disease spread. This review summarizes an update from current medical literature about the relationship between oral cavity and coronavirus disease by presenting some oral aspects which was detected in infected patients such as the oral lesions related to this virus and its therapeutic protocol, taste disorders and also the diagnostic value of saliva for SARS-CoV-2.


Author(s):  
Nathaniel O. Ajayi ◽  
Richard O. Awonusika ◽  
Adeniyi S. Ale ◽  
Ayooluwade Ebiwonjumi

The novel coronavirus (2019-nCoV) now known as Covid-19 was first detected in the city of Wuhan, China in December 2019. The disease rapidly spread to other cities in China and to other parts of the world. The aim of this study is to investigate the contribution which the economic zones and movement of people into the country and from city to city and State to State within the country have on the spread of the disease in Nigeria. Data of the daily update of Covid-19 occurrence in Nigeria as given by the NCDC Covid-19 Situation report were assembled. The data of the first index in each State between February 27 and March 28, 2020 with the status of whether they were from foreign travel or from within the community was compiled. The results show that economic zones and human movement contribute to the early spread of the disease. The initial spatial spread in Nigeria was observed to follow closely behind the test laboratory distribution pattern. This may suggest that samples from the locations far from the laboratories were not obtained, hence the suggestion for early aggressive country-wide-large scale testing to cover almost everyone should be started very early before the spread is everywhere. The test labs should cover the whole country with the tests made free and mandatory to encourage and force people to come out for it and the restriction protocols should strictly be adhered to. The boarders of the country should be closed early to stop further import of the disease from the high risk countries. When the airports are later re-opened, they should not be to the high-risk countries of the disease. There is also a need for a national policy on responding to and managing any future public health crisis such as Covid-19 pandemic before its occurrence. This policy will help the government to know what to start doing quickly when there is any occurrence. Government should also look inward to mobilize the scientists inside the country by providing research grants purposely to combat the pandemic. Such grants will enable our scientists to make their contribution in addition to the ones made by the scientists outside the country.


European View ◽  
2020 ◽  
Vol 19 (2) ◽  
pp. 154-163
Author(s):  
Nad’a Kovalčíková ◽  
Ariane Tabatabai

As governments and citizens around the world have struggled with the novel coronavirus, the information space has turned into a battleground. Authoritarian countries, including Russia, China and Iran, have spread disinformation on the causes of and responses to the pandemic. The over-abundance of information, also referred to as an ‘infodemic’, including manipulated information, has been both a cause and a result of the exacerbation of the public health crisis. It is further undermining trust in democratic institutions, the independent press, and facts and data, and exacerbating the rising tensions driven by economic, political and societal challenges. This article discusses the challenges democracies have faced and the measures they have adopted to counter information manipulation that impedes public health efforts. It draws seven lessons learned from the information war and offers a set of recommendations on tackling future infodemics related to public health.


2021 ◽  
Vol 15 (03) ◽  
pp. 366-369
Author(s):  
Rooh Ullah ◽  
Muhammad Suleman Rana ◽  
Mehmood Qadir ◽  
Muhammad Usman ◽  
Niaz Ahmed

Pandemic of novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections in China is now become global public health crisis. At present 87.64% of the world is infected by this deadly illness. The risk from this epidemic depends on the nature of the virus, including how well it transmits from person to person, and the complications resulting from this current illness. The novel coronavirus has killed thousands of people in China and other countries as well; its rate of mortality is increasing day by day. There is an urgent need to control the virus by developing vaccine or any other antiviral drugs to save the world from this deadly viral infection.


Complexity ◽  
2021 ◽  
Vol 2021 ◽  
pp. 1-11
Author(s):  
Lingbo Li ◽  
Ying Fan ◽  
An Zeng ◽  
Zengru Di

The novel coronavirus (COVID-19) pandemic is intensifying all over the world, but some countries, including China, have developed extensive and successful experience in controlling this pandemic. In this context, some questions arise naturally: What can countries caught up in the epidemic learn from China’s experience? In regions where the outbreak is under control, what would lead to a resurgence of the epidemic? To address these issues, we investigate China’s experience in anticontagion interventions and reopening process, focusing on the coevolution of epidemic and awareness during COVID-19 outbreak. Through an empirical analysis based on large-scale data and simulation based on a metapopulation and multilayer network model, we ascertain the impact of human movements and awareness diffusion on the epidemic, elucidate the inherent patterns and effective interventions of different epidemic prevention methods, and highlight the crunch time of each measure. The results are also employed to analyze COVID-19 evolution in other countries so as to find unified rules in complex situations around the world and provide advice on anticontagion and reopening policies. Our findings explain some key mechanisms of epidemic prevention and may help the epidemic analysis and decision-making in various countries suffering from COVID-19.


Author(s):  
Neha Saini ◽  
Prem Pandey ◽  
Mandar Shirolkar ◽  
Atul Kulkarni

Humanity is going through never seen before health crisis due to the outbreak of novel coronavirus or Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). There are 24.02 million cases and 0.82 million deaths worldwide as of 26th August 2020 due to deadly infection of COVID-19. The disease has been spreading exponentially (R-naught number: 3) and has challenged even the best healthcare infrastructure in the world. With the progression of the disease, the countries shifted the focus from cure to diagnosis and containment to flatten the curve. The review shows that the disease is spreading exponentially while the resources are still limited. We focus upon the probable vectors of the virus, different diagnostic methods with advantages & limitations, and the way forward. This review article covers the different diagnostic methods with more advantages, limitations, and the future sneak-peek into the forthcoming developments for the diagnostic processes such as RT-PCR (Reverse Transcription Polymerase chain reaction).


Author(s):  
Antoine Danchin ◽  
Tuen Wai Ng ◽  
Gabriel Turinici

Abstract Background: A novel coronavirus spread starting late 2019 from the capital of the Hubei province in China to the rest of the country, then to most of the world. To anticipate future trends in the development of the epidemic, we explore here, based on public records of infected persons how variation in the virus tropism could end up in different patterns, warranting specific way to handle the epidemic. Methods: We use a compartmental model to describe the evolution of an individual through several possible states: susceptible, infected, alternative infection, detected and removed. We t the parameters of the model to the existing data taking into account significant quarantine changes where necessary. Results: The model indicates that Wuhan quarantine measures were effective but that alternative virus forms and a second propagation route are compatible with available data. For Hong Kong, Singapore and Shenzhen region the secondary route does not seem to be active yet and the epidemic size limited. Conclusions: The alternative infection tropism (the gut tropism) and a secondary propagation route hypotheses are validated using a model fitted by the available data. Corresponding prevention measures that take into account both routes should be implemented to the benefit of epidemic control.


2020 ◽  
Vol 11 (SPL1) ◽  
pp. 94-102
Author(s):  
Prasaath Sastha K R ◽  
Balasubramanian Arul ◽  
Ramalingam Kothai

It all started in December 2019, a seafood market in Wuhan, China, with a series of pneumonia alike cases admitted with severe acute respiratory depression. Since they were unable to detect the precise cause, they named it "Pneumonia of unknown etiology". Later it was identified as SARS COV 2 (Severe Acute Respiratory Syndrome – coronavirus 2). At first, the disease spread locally affecting the people of Wuhan, and then started spreading throughout China, creating a worldwide panic. The World Health Organization (WHO) declared COVID-19 in China as a Public Health Emergency of International Concern. The Center for Disease Control and Prevention (CDC) from China and local healthcare units organized an intensive outbreak investigation program. The causative organism of this infection is a new virus that belongs to the “coronavirus (CoV)” family. After which the disease was called nCoV-19 (Novel coronavirus – 19). On February 11, 2020, the WHO Director General, Dr. Tedros Adhanom Ghebreyesus, renamed the disease as "COVID-19," which is the acronym of "coronavirus disease 2019". Viral epidemics like SARS-CoV in 2002, H1N1 influenza in 2009, and the most recent one the MERS-CoV Middle East Respiratory Distress Syndrome Coronavirus (first identified in Saudi Arabia) in 2012 threatened the health of mankind in the past two decades. All of these were successfully prevented by systematically approaching the problem to solve it. Healthcare professionals around the world are well trained to manage any type of health crisis. On March 11, 2020, the WHO declared COVID-19 as a "PANDEMIC" pointing to over 118,000 cases and 80,000 dead in 110 countries or more. In a media briefing, the WHO Director General said: "This is not just a public health crisis, it is a crisis that will touch every sector, so every sector and every individual must be involved in the fight."


Coronaviruses ◽  
2021 ◽  
Vol 02 ◽  
Author(s):  
Ayushi Mahajan ◽  
Lakhvir Kaur ◽  
Gurjeet Singh ◽  
RK Dhawan ◽  
Lovepreet Singh ◽  
...  

: The year 2020 was the most challenging period for all due to the havoc caused by the outbreak of novel coronavirus SARS-CoV-2. Scientists and researchers all around the world have endeavored every possible approach to find solutions in context to therapeutics and vaccines to control the spread of this life-threatening virus. The acceleration instigated by the outbreak of SARS-CoV-2 and its mutated strains has leveraged the use of numerous platform technologies for the development of vaccines against this unfathomable disease. Vaccines could play an important role in mitigating the effects of COVID-19 and reducing the ongoing health crisis. Various innovative platforms like proteins, nucleic acids, viruses, and viral vectors have been exploited to fabricate vaccines depicting almost 90% of efficacy like BNT162b2, AZD1222, Ad5-nCoV, etc. Some of these vaccines are multipotent and have shown potent activity against newly emerged malicious strains of SARS-CoV-2 like B.1.351andB.1.1.7. In this review article, we have gathered key findings from various sources of recently popularized vaccine candidates which will provide an overview of potential vaccine candidates against this virus and will help the researchers to investigate possible ways to annihilate this menace and design new moieties.


Sign in / Sign up

Export Citation Format

Share Document